Current Affairs – July, 2015

Latest Current Affairs July, 2015 with Current Affairs, news summary on current events of National and International importance of July, 2015 for Banking, SSC, CLAT, UPSC, State PCS, IBPS, Railways and other Competitive Examinations.

PDF Compilation of these updates can be downloaded from This Link

Matti Makkonen, Father of SMS technology passes away

Finnish telecom engineer and father of messaging service (SMS) technology Matti Makkonen passed away following serious illness. He was 63.

In 1984, he had pioneered the idea of sending messages via mobile networks but failed to patent it was merely idea and was not actual implementation.

About Matti Makkonen

  • Matti Makkonen was born on 16 April 1952 in Suomussalmi, Finland. He had graduated as an electrical engineer from the Oulu technical college in 1976.
  • He had started his career at Telecoms and Postal agency (PTL) as a systems engineer from (1976–1983). He had served as vice president of PTL and was actively involved in the development of the GSM-technology from 1984 to 1988.
  • In 1989, he was appointed as President of the mobile communication unit which was later renamed as Telecom Finland.
  • In 2008, for his work on SMS he was awarded The Economist’s Innovation Award in the computing and telecommunications category.

Interesting facts

  • The first text message was sent via the Vodafone network from a computer to a mobile device in December 1992.
  • In 1994, Nokia became first mobile manufacturer to introduce phone i.e. Nokia 2010 to write and send SMS.

Get these updates on Current Affairs Today Android App

First potential treatment for deadly MERS virus identified by scientists

For the first time scientists have identified two promising drug candidates for the treatment of deadly Middle East Respiratory Syndrome (MERS)  virus.

REGN3051 and REGN3048 are the two antibodies (drug candidates) which have shown ability to neutralise the MERS virus. This research was done in collaboration with New York based biopharmaceutical company Regeneron.

Research Summary

In order to validate effective antibodies to target MERS virus, researchers had relied on Regeneron’s VelociGene technology to create partially humanised mice that can be infected with MERS.

This partially humanised mouse model will help researchers further to boost their ability to study potential treatments. It will in turn help scientists to understand how the virus causes disease in people

About Middle East Respiratory Syndrome (MERS)

  • MERS belongs to the family of coronaviruses which includes large family of viruses such as common cold and Severe acute respiratory syndrome (SARS).
  • It was discovered in 2012 and was mostly centred in Saudi Arabia.
  • Source: MERS is a betacoronavirus derived from bats. Camels have shown to have antibodies to MERS, but the exact source of infection in camels has not been identified.
  • Transmission: It can be transmitted from infected person to others after close contact via a respiratory route. It spread’s in droplets when an infected person coughs or sneezes.
  • Symptoms: fever, breathing problems, pneumonia and kidney failure.
  • Treatment: Till date there is no vaccine available to prevent it. However intensive medical care can help patient to breath.

Get these updates on Current Affairs Today Android App

Advertisement